Akums Drugs and Pharmaceuticals, a leading contract manufacturing pharma company in India, is contributing to the rapid growth of the Indian pharma industry
Life expectancy has increased by several years during the millennium thanks to specific ailment-based medicines developed by scientists and produced by manufacturing companies. Medicines have quantifiable impact on the betterment of quality of lives and contributing towards a healthy lifestyle with preventive and curative measures.
The Indian pharmaceutical industry, the largest in terms of volume and 13th in value globally, has grown with leaps and bounds to become a global identity. It is estimated to grow at a CAGR of 12 per cent till 2020. The fast Indian pharma growth story is no wonder contributed by few leading marketing companies of the country but has also been contributed by Akums Drugs and Pharmaceuticals, a leading and one of the largest contract manufacturing pharma company of India. Currently, most of the leading marketing companies in India as well as in global pharma market are outsourcing formulations and focus entirely on evolving marketing strategies and launching newer molecules.
Akums Drugs and Pharmaceuticals was established in 2004, which is a pioneer in setting new trends in Contract Research and Manufacturing Services (CRAMS) and offers innovative solutions developed by its R&D and F&D departments for complex and challenging health issues to the society through its marketing associates.
In a span of 11 years, Akums has become a highly reputed contract manufacturing pharma company of India for its high quality products and unique business acumen. Currently, Akums is manufacturing more than 10 per cent of India’s total medicinal requirement. Products manufactured by Akums are being preferred by the medical fraternity because of their trust on efficacy, safety and quality of formulations. Over the years, Akums has become a brand in itself.
Akums, in the last one decade, has set up nine ultra modern manufacturing facilities of international standards in Haridwar, Uttarakhand for manufacturing formulations in the form of tablets, hard and soft gelatine capsules, dry and liquid orals, medicinal jellies, oral powder in jars and sachets, dry and liquid injectables in vials and ampoules, pre-filled syringes, large volume parenterals, lyophilised products, eye/ ear/ nasal drops (FFS & 3 piece packs), ointments, creams, lotions, diskettes etc. covering most of the therapeutic segments including, hormonal, cardio-vascular, anti-diabetic, gynaecological, dermatological, nutraceutical, cosmeticeuticals herbal as well as OTC products.
Akums business covers Contract Research & Manufacturing Services (CRAMS) and is actively engaged in domestic, export and institutional business; formulation and development of Novel Drug Delivery System (NDDS) products and technical collaboration and joint ventures.
Akums’ unique competence lies in developing specialised new formulations, conducting stability studies, undertaking bio-equivalence studies, clinical trials and obtaining DCG(I) (Indian FDA) approvals for manufacturing new fixed dosage combinations and molecules and thereby offering new formulations to its clients with Akums’ technology under their brand names. Akums has already got 500 DCG(I) approvals, which is highest in number awarded to any company in the country and a large number of applications are in the pipeline.
The facilities are accredited with WHO-GMP, ISO 9001-2008, ISO 14001-2004, HACCP, Certificate from NABL with ISO/IEC 17025:2005 and US-NSF,GMP-Ayush, Food Safety Systems: 1999 for its herbal and nutraceutical, Maxcure Nutravedic facility.
Akums has not kept itself limited to the Indian domestic market and its facilities have been approved by various international regulatory bodies, like: ANVISA-Brazil, NAFDAC-Nigeria, PPB-Kenya, NDA-Uganda, FDB-Ghana, PMPB-Malawi, MOH-Libya, CD & DA-Sri Lanka, DPM-Ivory Coast, MOH-Vietnam, MOH-Cambodia, MOH-Myanmar, MOH-Belarus, DDA-Nepal, MOH-Bhutan, MOH-Afghanistan, MOH-Yemen, etc.
Akums is exporting its internationally acknowledged formulations through its export subsidiary company Unosource Pharma from Mumbai to Libya, Nigeria, Ghana, Kenya, Uganda, Myanmar, Ethiopia, Liberia, Malawi, Phillipines, Vietnam, Sri Lanka, Nepal, Bhutan, Afghanistan, Malaysia, Venezuela, Belarus, Ukraine, Tajakistan, Honudrus, Francophone countries and many more.
Akums also manufactures a wide range of veterinary products in the form of bolus, liquid orals, injectables (dry/liquid), sprays, shampoos and feed additives in its different facilities with stringent quality control measures for leading Indian and multinational veterinary companies.
The cream of Indian pharma industries personnel in its QA & QC departments are the backbone of Akums. Akums has received many awards and accolades for its services in the field of pharma manufacturing, such as the National Award in 2010 for Excellence in Product Quality, National Award – 2010 by the Government of India for Outstanding Entrepreneurship, Rashtriya Udyog Ratna Award 2012-2014, Business Leadership Award 2012, for India’s most promising pharma company in CRAMS to name a few.
Comments are closed.